Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Condition: Mycosis Fungoides Intervention: Drug: Brentuximab vedotin Sponsors: M.D. Anderson Cancer Center; Seagen Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials